Since PPP1R1A is specifically and highly expressed in ES [3], inhibition of PPP1R1A will specifically inhibit ES cell proliferation and therefore constitute a specific and tolerable therapeutic strategy to control ES. Here, PPP1R1A is linked to Ewing sarcoma.